Study of Fluoxetine in Patients With Depersonalization Disorder

Exclusion Criteria

• •Prior or concurrent bio- or chemotherapy or
• •Use of any of the following within 2 weeks prior to study entry: antipsychotics, anticonvulsants, stimulants, barbiturates, lithium, benzodiazepines, or antidepressants
• •Use of MAO inhibitors or investigational drugs within 4 weeks prior to study entry
• •History of fluoxetine use at a dose of 10 mg or more for at least 6 weeks duration
• •Hematologic, hepatic, renal, cardiovascular, pulmonary, metabolic, endocrine, systemic, or gastrointestinal disease
• •History of mental disorders
• •Current substance abuse
• •Current eating disorder
• •Current clinically unstable suicidal ideation
• •Unstable medical illness
• •Clinically unstable
• •Clinically important abnormalities in lab tests or physical exams
• •History of seizure disorders or abnormal electroencephalogram
• •Hypersensitivity or severe side effects to fluoxetine
• •Pregnancy or breast-feeding. Women of child-bearing potential must use effective contraception